Skip to main content
Clinical Trials/NL-OMON50014
NL-OMON50014CompletedNot Applicable

The Role of the Immune System in Endometriosis - The Role of the Immune System in Endometriosis

niversitair Medisch Centrum Groningen0 sites20 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Patients between 18-56 years with confirmed endometriosis planned for
  • surgical excision of endometriosis
  • - Patients being able to read and understand the patient information form
  • - Signed informed consent

Exclusion Criteria

  • - History of an autoimmune disease, specifically hepatitis A virus (HAV),
  • hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency
  • virus (HIV), or any other systemic intercurrent disease or condition that might
  • affect the immunocompetence of the patient
  • - Treatment with systemic highly immunosuppressive therapy (e.g. transplant
  • recipients)
  • - Use of systemic continuous corticosteroid therapy (e.g. prednisone i.v. or
  • p.o. >7.5 mg/day)

Investigators

Similar Trials